https://www.selleckchem.com/pr....oducts/tulmimetostat
High-flow nasal cannula oxygenation (HFNC) and noninvasive positive-pressure ventilation (NPPV) possibly decrease tracheal reintubation rates better than conventional oxygen therapy (COT); however, few large-scale studies have compared HFNC and NPPV. We conducted a network meta-analysis (NMA) to compare the effectiveness of three post-extubation respiratory support devices (HFNC, NPPV, and COT) in reducing the mortality and reintubation risk. The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, and Ichushi database
Like
Comment
Share
